Indwelling pleural catheter infection and colonisation: a clinical practice review.
Autor: | Sethi DK; Quadram Institute Bioscience, Norwich, UK.; Department of Respiratory Medicine, Norfolk and Norwich University Hospitals Foundation Trust, Norwich, UK.; Norwich Medical School, University of East Anglia, Norwich, UK., Webber MA; Quadram Institute Bioscience, Norwich, UK.; Norwich Medical School, University of East Anglia, Norwich, UK., Mishra EK; Department of Respiratory Medicine, Norfolk and Norwich University Hospitals Foundation Trust, Norwich, UK.; Norwich Medical School, University of East Anglia, Norwich, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of thoracic disease [J Thorac Dis] 2024 Mar 29; Vol. 16 (3), pp. 2196-2204. Date of Electronic Publication: 2024 Mar 27. |
DOI: | 10.21037/jtd-23-1761 |
Abstrakt: | Indwelling pleural catheters (IPCs) are used in the management of malignant pleural effusions, but they can become infected in 5.7% of cases. This review aims to provide a summary of the development of IPC infections and their microbiology, diagnosis and management. IPC infections can be deep, involving the pleural space, or superficial. The former are of greater clinical concern. Deep infection is associated with biofilm formation on the IPC surface and require longer courses of antibiotic treatment. Mortality from infections is low and it is common for patients to undergo pleurodesis following a deep infection. The diagnosis of pleural infections is based upon positive IPC pleural fluid cultures, changes in pleural fluid appearance and biochemistry, and signs or symptoms suggestive of infection. IPCs can also become colonised, where bacteria are grown from pleural fluid drained via an IPC but without evidence of infection. It is important to distinguish between infection and colonisation clinically, and though infections require antibiotic treatment, colonisation does not. It is unclear what proportion of IPCs become colonised. The most common causes of IPC infection and colonisation are Staphylococcus aureus and Coagulase-negative Staphylococci respectively. The management of deep IPC infections requires prolonged antibiotic therapy and the drainage of infected fluid, usually via the IPC. Intrapleural enzyme therapy (DNase and fibrinolytics) can be used to aid drainage. IPCs rarely need to be removed and patients can generally be managed as outpatients. Work is ongoing to study the incidence and significance of IPC colonisation. Other topics of interest include topical mupirocin to prevent IPC infections, and whether IPCs can be designed to limit infection risk. Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1761/coif). The series “Malignant and Benign Pleural Effusions” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare. (2024 Journal of Thoracic Disease. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |